Research Processing Training Day Research Processing Training Day Introduction Best Research for Best Health Implication for N&S Bank R&D Consortium: redress.

Slides:



Advertisements
Similar presentations
NHS R&D Jessica Bisset Acting Research Operations Manager UH Bristol.
Advertisements

6th European Patients’ Rights Day The EMA Geriatric Medicines Strategy and the empowered aging patient Francesca Cerreta EMA (European Medicines Agency)
Research Within The NHS Prof Alison MacLeod Director Research & Development.
University Research Procedures Research Processing Training Day - 28 April 2006.
Getting research off the ground
NIHR Delivering Better Health 20 November 2012, Leeds Dr David Cox Deputy Director – Research Finance & Programmes.
Research Policy & Management RACD INTRODUCTION TO RESEARCH GOVERNANCE.
What are the challenges of successfully implementing homecare?
Exploring opportunities for health research collaborations between Australia and the UK Professor Nigel Mathers & Dr Susan Nancarrow Institute of General.
Changes to the Educational Landscape: an SHA perspective Tricia Ellis, Head of Knowledge Management and eLearning South West Technology Enhanced Learning.
UK Clinical Research Network (UKCRN) UK Clinical Research Network Maxine Stead PhD UKCRN Assistant Director – Clinical Trials.
Towards a New R&D Strategy A blueprint for R&D in Health and Social Care Noreen Caine Deputy Director of R&D, DH NHS R&D Forum Annual Conference May 2005.
West Midlands Academic Health Science Network
West Midlands Academic Health Science Network Mental Health Clinical Priority Event October 10 th, 2013 Peter Lewis Medical Director, Birmingham and Solihull.
West Midlands Academic Health Science Network
EU rare diseases registry for Niemann-Pick Disease type A, B and C Tarekegn Hiwot Consultant in Inherited Metabolic Disorders University Hospital of Birmingham.
MRC Funded Research Opportunities
Working in and career progression within an academic clinical trials unit Helen Thorpe Principal Statistician Clinical Trials Research Unit (CTRU) University.
Working together for better Research - Collaborative research with BCUHB Dr Nefyn Williams & Dr Richard Tranter, NWORTH Associate Clinical Directors &
“Best Research for Best Health” Andrew Riley Managing Director.
Welcome to the NIHR Peter Knight, Deputy Director Research Contracting, Information Intelligence and Stakeholder Engagement NIHR Trainees Meeting Leeds.
Responsible Sponsorship A case study Dr Birgit Whitman, Head of Research Governance.
Research Ethics-Integrity-Governance. University Initiative:The Catalyst? ‘02 Good Research Practice Standards & Procedure to Investigate Potential Research.
Overview of NIHR Grants Department of Psychology University of Essex 24 rd March 2009 Mike Bellhouse RDInfo.
Irish Health Research: Collaboration and Partnership HSE Regional Library & Information Health Research Seminar Dr. Steevens’ Hospital 11th February 2011.
Ian Williamson Chief Officer Greater Manchester Health and Social Care Devolution NW Finance Directors Friday 15 May 2015 Ian Williams Chief Officer Greater.
Improving Clinical Research across the UK – Who, Why, How? Matthew Hallsworth, Communications Programme Manager Marianne Miles, Patient and Public Involvement.
1 The UK Opportunity: what is experimental medicine? UNLOCK YOUR GLOBAL BUSINESS POTENTIAL Pre- clinical develop- ment Phase I Phase II Phase III Product.
NISCHR Research Infrastructure for Wales Angela Martin Learning Disabilities, Autism and Neurodevelopmental disorders network (LDAN) Conference April 2013.
999 EMS Research Forum Prioritisation of topics for research in prehospital care
Debbie Saunders External Funding Officer. External Funding Officers Chris Beynon ext 5015  Environment & Society;
Access to Clinical Expertise Steve Bain David Powell Jemma Hughes Paula Jeffries.
The Chief Scientist Office. Developments/Restructuring Of Research Funding In Scotland Overview of NHS Infrastructure funding ( ) What we have.
Michael Bowdery Interim Head of NISCHR
NIHR Delivering Better Health 26 November 2013, Leeds Dr David Cox Deputy Director – Research Finance & Programmes.
Evaluation Trials and Studies Coordinating Centre 5 July 2013 NIHR Programmes and topic identification Alison Ford, Senior Programme Manager.
NIHR CLAHRC for Northwest London Collaborations for Leadership in Applied Health Research and Care November 2008.
Research Roles in the NHS; Leadership and Capacity Building Dr Sally Fowler Davis- Clinical research/ Development Officer.
Dr David Jackson Clinical Lead for Research YCRN Co-director WYCLRN Yorkshire Palliative Medicine Regional Learning Group April 2008 Clinical Research.
PROCUREMENT & DISTRIBUTION INTEREST GROUP Autumn Symposium 2007
Research for Patient Benefit Overview of the programme in the West Midlands RDS West Midlands Exploring Research Funding Day 9 October 2013 Professor Scott.
The Role of the Research Office Joint Research & Enterprise Office (JREO) St George’s University of London and St George’s University Hospitals NHS Foundation.
CCF PPI 2009 Active patient and public involvement in research applications National Institute for Health Research Central Commissioning Facility Jean.
Developing a National Critical Care Clinical Research Network: what’s in it for trainees? Paul Dark Associate Professor, Faculty of Medical and Human Sciences,
Cardiff and Vale UHB Bwrdd lechyd Prifysgol Caerdydd a’r Fro NHS R&D Overview How to avoid the common pitfalls? Thomas Fairman Research Liaison Manager.
Our Plans for 2015/16 We want to make sure that people in our area are able to live long and healthy lives, both now and in the future, and our plans set.
R&D – a perspective Dr Nana Theodorou Research Coordinator Sheffield Clinical Research Office.
Adaptive Licensing UK. Content What is adaptive licensing? Draft criteria for pilot candidate selection EMA Road Map 2015 and work programme 2012 UK perspective.
NIHR Research Design Service London Enabling Better Research Dr Caroline Burgess General Adviser 13 th November 2013.
The Implementation Plan for Rare Diseases in Scotland abcdefghijklmnopqrstuabcdefghijklmnopqrstu.
Access to drugs, Reducing bottlenecks Matt Cooper Business Development & Marketing Director NIHR Clinical Research Network
Accessing the NHS for Research – NHS R&D Permissions Jemma Hughes R&D Manager ABMU Health Board.
Annual R&D Report Professor Graham Thornicroft. Achievements and Highlights 1 Specialist NIHR Biomedical Research Centre Technology Platform funding 6.
R&D Annual Report SLaM Board, Sept 2004 Graham Thornicroft Gill Dale.
Research & Development 2016 RESEARCH & DEVELOPMENT, West Suffolk Foundation Trust.
Foundation Doctors’ Academic Meeting Kathryn Adcock Wellcome Trust March 2011.
Public Health Research Programme Preventing the development and spread of Antimicrobial Resistance am - 2 October 2013 NIHR Public Health Research.
Building the NIHR NIHR: 10 years of delivering health and care research for the nation QEII Centre, London Wednesday 18 May 2016 Professor Dame Sally C.
GCP (GOOD CLINICAL PRACTISE)
Diabetes Research Network Professor Azeem Majeed Imperial College, London.
Scrutiny Commission 3 Scrutiny of Health 30 September 2002 Jane Lewington Chief Executive North East Lincolnshire PCT.
Leicestershire, Northamptonshire and Rutland Comprehensive Local Research Network Improving the health and wealth of the nation through research: Local.
CLINICAL TRIALS.
London (South) Comprehensive Local Research Network
NIHR Invention for Innovation (i4i)
The Essentia Institute of Rural Health (EIRH) is
Help with developing research projects - Introducing the NIHR Research Design Service (RDS) Talked about ways into research and the next session looks.
UKCRC Translational Infection Research Initiative
How the RDS can support your application
An Introduction to the NIHR programmes
Presentation transcript:

Research Processing Training Day Research Processing Training Day Introduction Best Research for Best Health Implication for N&S Bank R&D Consortium: redress last 10 years of funding deficiency Consortium Web Resources

North & South Bank NHS R&D Consortium The Consortium is as NHS R&D partnership between Hull & East Yorkshire Hospitals NHS Trust, Humber Mental Health Teaching Trust, North Lincolnshire & Goole Hospitals NHS Trust, along with University of Hull. The Consortiums R&D programmes are: Assessment and interventions for long-term child mental health problems Bio-psycho-social interventions in primary care for mental health problems of older people Evaluating new mental health services Musculo-skeletal injuries and disorders Technologies for serious mental illness User-centred research Cancer: investigation, diagnosis and treatment – optimisation of primary, secondary and tertiary care services input Cardiovascular & pulmonary: a comprehensive approach to the natural history, diagnosis, and care of heart failure, cardiovascular disease, mechanisms and management of cough Metabolism in health and disease First episode research network Psychological therapies in health service settings

DH Research Strategy: Background 1997Assumption that Routine NHS Funding Supporting R&D - R&D levy defined (Culyer, Budget1) - N&S Bank Consortium 2006/07 ~ £1.1m c.f. Sheffield ~ £8m, Leeds ~ £10m, London ~ £302m 1998 National Programmes - Cochrane Collaboration & Centre for Reviewers & Dissemination - Health Technology Assessment (HTA) - Service Delivery & Organisation (SDO) - New & Emerging Applications Technology (NEAT) 2001 Research Governance Framework to ensure that health and social care research is conducted to high scientific and ethical standards that earn public confidence 2002– Legislative Framework - Data Protection Act - Mental Capacity Act - Human Tissue Act - Local research ethics committees COREC - EU Clinical Trials Directive - Medicines for Human Use (Clinical Trials) Regulations - Research Governance Framework 2 nd Edition

DH Research Strategy: Background 1997Assumption that Routine NHS Funding Supporting R&D - R&D levy defined (Culyer, Budget1) - N&S Bank Consortium 2006/07 ~ £1.1m c.f. Sheffield ~ £8m, Leeds ~ £10m, London ~ £302m 1998 National Programmes - Cochrane Collaboration & Centre for Reviewers & Dissemination - Health Technology Assessment (HTA) - Service Delivery & Organisation (SDO) - New & Emerging Applications Technology (NEAT) 2001 Research Governance Framework to ensure that health and social care research is conducted to high scientific and ethical standards that earn public confidence 2002– Legislative Framework - Data Protection Act - Mental Capacity Act - Human Tissue Act - Local research ethics committees COREC - EU Clinical Trials Directive - Medicines for Human Use (Clinical Trials) Regulations - Research Governance Framework 2 nd Edition

DH Research Strategy: Background 1997Assumption that Routine NHS Funding Supporting R&D - R&D levy defined (Culyer, Budget1) - N&S Bank Consortium 2006/07 ~ £1.1m c.f. Sheffield ~ £8m, Leeds ~ £10m, London ~ £302m 1998 National Programmes - Cochrane Collaboration & Centre for Reviewers & Dissemination - Health Technology Assessment (HTA) - Service Delivery & Organisation (SDO) - New & Emerging Applications Technology (NEAT) 2001 Research Governance Framework to ensure that health and social care research is conducted to high scientific and ethical standards that earn public confidence 2002– Legislative Framework - Data Protection Act - Mental Capacity Act - Human Tissue Act - Local research ethics committees COREC - EU Clinical Trials Directive - Medicines for Human Use (Clinical Trials) Regulations - Research Governance Framework 2 nd Edition

DH Research Strategy: Background 1997Assumption that Routine NHS Funding Supporting R&D - R&D levy defined (Culyer, Budget1) - N&S Bank Consortium 2006/07 ~ £1.1m c.f. Sheffield ~ £8m, Leeds ~ £10m, London ~ £302m 1998 National Programmes - Cochrane Collaboration & Centre for Reviewers & Dissemination - Health Technology Assessment (HTA) - Service Delivery & Organisation (SDO) - New & Emerging Applications Technology (NEAT) 2001 Research Governance Framework to ensure that health and social care research is conducted to high scientific and ethical standards that earn public confidence 2002– Legislative Framework - Data Protection Act - Mental Capacity Act - Human Tissue Act - Local research ethics committees COREC - EU Clinical Trials Directive - Medicines for Human Use (Clinical Trials) Regulations - Research Governance Framework 2 nd Edition

2003 Academy of Medical Sciences -consequences for health from inadequate support or R&D -need for NHS/industry collaboration -need for supportive public and regulatory environment for innovation -requirement for sufficient and sustainable funding 2004 The Walport Report on Clinical Academic Careers Government Science and Innovation Investment Framework Research for Patient Benefit Working Party -UK Clinical Research Collaboration (UKCRC) -need for NHS R&D strategy 2006 Best Research for Best Health: - Vision: to improve the health and wealth of the nation through research - Mission: to create a health research system in which the NHS supports outstanding individuals, working in world-class facilities, conducting leading-edge research, focused on the needs of patients and the public - Funding: Phase out Budget1 over 3 year period DH Research Strategy: Re-Assessment

2003 Academy of Medical Sciences -consequences for health from inadequate support or R&D -need for NHS/industry collaboration -need for supportive public and regulatory environment for innovation -requirement for sufficient and sustainable funding 2004 The Walport Report on Clinical Academic Careers Government Science and Innovation Investment Framework Research for Patient Benefit Working Party -UK Clinical Research Collaboration (UKCRC) -need for NHS R&D strategy 2006 Best Research for Best Health: - Vision: to improve the health and wealth of the nation through research - Mission: to create a health research system in which the NHS supports outstanding individuals, working in world-class facilities, conducting leading-edge research, focused on the needs of patients and the public - Funding: Phase out Budget1 over 3 year period DH Research Strategy: Re-Assessment

2003 Academy of Medical Sciences -consequences for health from inadequate support or R&D -need for NHS/industry collaboration -need for supportive public and regulatory environment for innovation -requirement for sufficient and sustainable funding 2004 The Walport Report on Clinical Academic Careers Government Science and Innovation Investment Framework Research for Patient Benefit Working Party -UK Clinical Research Collaboration (UKCRC) -need for NHS R&D strategy 2006 Best Research for Best Health: - Vision: to improve the health and wealth of the nation through research - Mission: to create a health research system in which the NHS supports outstanding individuals, working in world-class facilities, conducting leading-edge research, focused on the needs of patients and the public - Funding: Phase out Budget1 over 3 year period DH Research Strategy: Re-Assessment

R&D Challenges

National Institute for Health Research

Release call/ outline applications Shortlisting for outline applications/ call for full proposals Deadline for full proposals Awards Jan FebMarAprMayJunJulyAugSepOctNovDec Technology Platforms (Imaging) - Implementation plan 5.3 Overview of NIHR Research Projects, Programmes Units and Centres - Implementation plan 6.1 Research for Patient Benefit (RFPB) Project Scheme - Implementation plan 6.2 Research for Innovation, Speculation and Creativity (RISC) Project Scheme - Implementation plan 6.2 Health Technology Assessment (HTA) Programme - Implementation plan 6.3 Service Delivery and Organisation (SDO) Programme - Implementation plan 6.3 Invention for Innovation Programme - Implementation plan 6.4 Programmes Grants for Applied Research - Implementation plan 6.5 Research Centres for NHS Service Quality and Safety - Implementation plan 6.7 Biomedical Research Centres - Implementation plan 6.7

Purpose: To establish a dedicated funding stream to support NHS costs of selected technology platforms for health research in NHS providers Budget: Rising from £8m - £50m p.a. Implementation: - Diagnostic imaging (MRI, fast multi-slice CT & PET) - Must have established project portfolio - Support to increase R&D capacity (i.e. sessional time) - Bid Deadline: May 25 Technology Platforms Networks Purpose: To support and conduct RCTs of interventions funded by commercial and grant sources Budget: not specified Implementation: - Cancer in place - March 06: comprehensive research network across all non-topic specific areas. - April 06: new networks for Diabetes, Stroke, Dementias & Neurodegenerative Diseases - £2m

Purpose: To establish a dedicated funding stream to support NHS costs of selected technology platforms for health research in NHS providers Budget: Rising from £8m - £50m p.a. Implementation: - Diagnostic imaging (MRI, fast multi-slice CT & PET) - Must have established project portfolio - Support to increase R&D capacity (i.e. sessional time) - Bid Deadline: May 25 Technology Platforms Networks Purpose: To support and conduct RCTs of interventions funded by commercial and grant sources Budget: not specified Implementation: - Cancer in place - March 06: comprehensive research network across all non-topic specific areas. - April 06: new networks for Diabetes, Stroke, Dementias & Neurodegenerative Diseases - £2m

Commercial Trial Verbally agreed with PI \ PI Defines Study Information received (Protocol contract etc) (either company approached us or we approached company) Decide if audit, donation (MOU and annexe 1 required), clinical trial (drug or device), service AUC send appropriate template CTA to Funder \ Complete Application Form Include contacts (N Dunham, E Lindstrom, G Byron, J Cant) Send copy of contract from Funder to Nina\Elaine (Trust R&D) and J. Cant\G. Byron (University) Contact AUC and Trust R&D PI Complete Trust R&D resource form CORREC MREC etc Apply for Ethics\Audit if required (copy ethics to AUC & Research Office, Resource form to R&D Protocol etc to R&D, AUC, G.Byron, J Cant) Risk Assessment if required Annexe 1 if required Negotiate Contract, ensure cost and recruitment is realistic Negotiate Overhead, Travel Costs, Trust Costs, VAT etc Contract Agreed Final contracts signed by Funder to AUC Complete RAR form Set Budget Staff Costing from University Research Office, Obtain Quotes Obtain Signatures on RAR form: Lead Investigator S Giddings Prof Stafford Forward RAR & Contracts to Research Office Team Mark Hawksworth & J Cant negotiate Annexe 1 if required Sign contracts (only signed if all documentation inc Ethics approval is with the Research Office) Return Contracts to AUC Contracts /Grant Application to Trust R&D for D Hepburn Signature Trust Approval Post Contract to Funder / Submit Grant Application Contract \ Grant announced by Post Award team (S Marsters) Timescale Is this a Charity / Research Council application or a Commercial Trial? AUC: Academic Unit Contact CTA: Clinical Trials Agreement Sponsor is someone who will monitor or who has legal responsibility, Funder can be sponsor PI Dept Trials Manager Dept Admin Dept Admin, Trust R&D, G Byron, J Cant Dept Admin J Cant Trust R&D Dept Admin Post Award Finance Team Dept Admin Ensure version numbers are used on contracts If Company will not accept CTA then G. Byron must approve their version of contract Day 1 Day 90 Use colours to tie in RAR forms and Specify names of those responsible at each step Version 1.3

Summary DH R&D Strategy – Best Research for Best Health Tremendous opportunities Highly competitive Challenge Get in early Focus initially on our current strengths Consortium Website Aimed at being centralised resource base Feedback encouraged and welcome!